コセンティクス医薬品の世界市場レポート 2025年：疫学、パイプライン分析、市場インサイトと予測

コセンティクス医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9%で80億3,080万米ドルに成長します。予測期間の成長は、自己免疫疾患の有病率の増加、承認された適応症の拡大、生物学的療法の進歩、有利な償還施策、強力な臨床成績に起因すると考えられます。予測期間における主要動向としては、自己免疫疾患への適応拡大、個別化医療へのシフト、皮下投与の優位性、新規治療領域における研究開発などが挙げられます。

自己免疫疾患の増加は、コセンティクス市場の成長を牽引すると予想されます。自己免疫疾患は、免疫系が誤って身体の健康な細胞や組織を攻撃することで発症します。この増加は、遺伝的素因、環境の影響（感染症や汚染物質など）、ストレスレベルの上昇や食生活の変化などのライフスタイルの変化といった要因に起因しています。コセンティクス（一般名：セクキヌマブ）は、炎症プロセスに関与するサイトカインであるインターロイキン-17Aを標的として阻害することにより、自己免疫疾患の治療に重要な役割を果たします。これにより、症状を軽減し、生活の質を改善し、乾癬、乾癬性関節炎、強直性脊椎炎などの疾患を効果的に管理することができます。例えば、2023年7月、スコットランド公衆衛生局は、2022年に新たに多発性硬化症（MS）と診断された患者数が87.2%増加したことを報告し、自己免疫疾患の有病率の増加を浮き彫りにし、コセンティックスのような治療に対する需要を牽引しています。

ヘルスケア支出の増加がコセンティクス市場を促進すると予想されます。高齢化、慢性疾患、高度医療技術、薬価の上昇を背景としたヘルスケアサービスへの支出の増加は、コセンティックスのような生物製剤への投資拡大につながっています。生物製剤は、特に中等度から重度の乾癬、乾癬性関節炎、強直性脊椎炎の治療に使用され、標的治療を通じて患者の予後を改善します。2024年5月、英国国家統計局は、2022～2023年にかけてのヘルスケア総支出が5.6%増加すると報告しており、ヘルスケアと生物製剤による治療に対する財政的コミットメントが高まっていることをさらに強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のコセンティクス医薬品：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のコセンティクス医薬品市場：成長率分析
• 世界のコセンティクス医薬品市場の実績：規模と成長、2019～2024年
• 世界のコセンティクス医薬品市場の予測：規模と成長、2024～2029年、2034年
• 世界のコセンティクス医薬品：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のコセンティクス医薬品市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• 化膿性汗腺炎
• 乾癬性関節炎
• 強直性脊椎炎
• 尋常性乾癬
• 世界のコセンティクス医薬品市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 皮下注射
• 静脈内注入
• 世界のコセンティクス医薬品市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• オンライン薬局
• 小売薬局

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のコセンティクス医薬品市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のコセンティクス医薬品市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• コセンティクス医薬品市場：競合情勢
• コセンティクス医薬品市場：企業プロファイル
  • Novartis AG
  • Sandoz
  • D. Vijay Pharma Private Limited
  • KinBio
  • Zymeth Pharmaceuticals Private Limited

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• コセンティクス医薬品市場、2029年：新たな機会を提供する国
• コセンティクス医薬品市場、2029年：新たな機会を提供するセグメント
• コセンティクス医薬品市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Cosentyx (secukinumab) is a prescription biologic medication developed by Novartis. It is a monoclonal antibody that targets interleukin-17A (IL-17A), a protein involved in inflammation. Cosentyx is primarily used to treat autoimmune conditions such as plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Administered via subcutaneous injection, it helps reduce inflammation, alleviate skin symptoms, and prevent joint damage. The drug has demonstrated effectiveness in improving the quality of life for patients suffering from these chronic conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary indications for cosentyx include hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Hidradenitis suppurativa is a chronic skin condition that causes painful lumps, abscesses, and scarring, typically in areas with sweat glands such as the underarms and groin. The routes of administration include subcutaneous injection and intravenous infusion, with distribution channels encompassing hospital pharmacies, online pharmacies, and retail pharmacies.

The cosentyx drug market research report is one of a series of new reports from The Business Research Company that provides cosentyx drug market statistics, including cosentyx drug industry global market size, regional shares, competitors with a cosentyx drug market share, detailed cosentyx drug market segments, market trends and opportunities, and any further data you may need to thrive in the cosentyx drug industry. This cosentyx drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cosentyx drug market size is expected to see strong growth in the next few years. It will grow to $8,030.8 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to the increasing prevalence of autoimmune diseases, expansion of approved indications, advancements in biologic therapies, favorable reimbursement policies, and strong clinical outcomes. Major trends in the forecast period include expanding applications for autoimmune diseases, shifting toward personalized medicine, and the dominance of subcutaneous administration and R&D in new therapeutic areas.

The increasing prevalence of autoimmune diseases is expected to drive the growth of the cosentyx market. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy cells and tissues. This rise can be attributed to factors such as genetic predisposition, environmental influences (e.g., infections and pollutants), and lifestyle changes, including higher stress levels and dietary shifts. Cosentyx (secukinumab) plays a vital role in treating autoimmune conditions by targeting and inhibiting interleukin-17A, a cytokine involved in the inflammatory process. This helps reduce symptoms, improve the quality of life, and manage conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis effectively. For example, in July 2023, Public Health Scotland reported that the number of newly diagnosed multiple sclerosis (MS) patients increased by 87.2% in 2022, highlighting the growing prevalence of autoimmune diseases and driving demand for treatments like cosentyx.

Rising healthcare expenditure is expected to propel the cosentyx market. Increased spending on healthcare services, driven by an aging population, chronic diseases, advanced medical technology, and higher drug prices, has led to more investment in biologic therapies like Cosentyx. The biologic drug is especially used in managing moderate to severe psoriasis, psoriatic arthritis, and ankylosing spondylitis, improving patient outcomes through targeted therapy. In May 2024, the UK's Office for National Statistics reported a 5.6% rise in total healthcare expenditure from 2022 to 2023, further highlighting the increasing financial commitment to healthcare and biologic treatments.

A key trend in the cosentyx market is the development of advanced biological therapies to address unmet medical needs and improve treatment efficacy. Cosentyx is part of this trend, with a focus on managing chronic autoimmune conditions using targeted therapies. For instance, in October 2023, Novartis AG, a Switzerland-based pharmaceutical company, received FDA approval for Cosentyx as the first new biologic treatment option for moderate to severe hidradenitis suppurativa (HS) in nearly a decade. This approval represents a significant advancement in HS treatment, demonstrating Cosentyx's growing role in autoimmune disease management and expanding its market reach.

Key player operating in the cosentyx drug market is Novartis AG

North America was the largest region in the cosentyx drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cosentyx drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cosentyx drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cosentyx drug market consists of sales oflyophilized powder, and self-administered autoinjector. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cosentyx Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cosentyx drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cosentyx drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cosentyx drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Indication: Hidradenitis suppurativa; Psoriatic arthritis; Ankylosing spondylitis; Plaque Psoriasis
• 2) By Route Of Administration: Subcutaneous injection; Intravenous infusion
• 3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
• Companies Mentioned: Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cosentyx Drug Market Characteristics

3. Cosentyx Drug Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Cosentyx Drug Market Trends And Strategies

5. Cosentyx Drug Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Cosentyx Drug Growth Analysis And Strategic Analysis Framework

• 6.1. Global Cosentyx Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Cosentyx Drug Market Growth Rate Analysis
• 6.4. Global Cosentyx Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Cosentyx Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Cosentyx Drug Total Addressable Market (TAM)

7. Global Cosentyx Drug Market Pricing Analysis & Forecasts

8. Cosentyx Drug Market Segmentation

• 8.1. Global Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hidradenitis suppurativa
• Psoriatic arthritis
• Ankylosing spondylitis
• Plaque Psoriasis
• 8.2. Global Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subcutaneous injection
• Intravenous infusion
• 8.3. Global Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

9. Global Cosentyx Drug Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Cosentyx Drug Market Regional And Country Analysis

• 10.1. Global Cosentyx Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Cosentyx Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Cosentyx Drug Market

• 11.1. Asia-Pacific Cosentyx Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Cosentyx Drug Market

• 12.1. China Cosentyx Drug Market Overview
• 12.2. China Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Cosentyx Drug Market

• 13.1. India Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Cosentyx Drug Market

• 14.1. Japan Cosentyx Drug Market Overview
• 14.2. Japan Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Cosentyx Drug Market

• 15.1. Australia Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Cosentyx Drug Market

• 16.1. South Korea Cosentyx Drug Market Overview
• 16.2. South Korea Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Cosentyx Drug Market

• 17.1. Western Europe Cosentyx Drug Market Overview
• 17.2. Western Europe Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Cosentyx Drug Market

• 18.1. UK Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Cosentyx Drug Market

• 19.1. Germany Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Cosentyx Drug Market

• 20.1. France Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cosentyx Drug Market

• 21.1. Eastern Europe Cosentyx Drug Market Overview
• 21.2. Eastern Europe Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Cosentyx Drug Market

• 22.1. North America Cosentyx Drug Market Overview
• 22.2. North America Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Cosentyx Drug Market

• 23.1. USA Cosentyx Drug Market Overview
• 23.2. USA Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Cosentyx Drug Market

• 24.1. Canada Cosentyx Drug Market Overview
• 24.2. Canada Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Cosentyx Drug Market

• 25.1. South America Cosentyx Drug Market Overview
• 25.2. South America Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Cosentyx Drug Market

• 26.1. Middle East Cosentyx Drug Market Overview
• 26.2. Middle East Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Cosentyx Drug Market

• 27.1. Africa Cosentyx Drug Market Overview
• 27.2. Africa Cosentyx Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Cosentyx Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Cosentyx Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Cosentyx Drug Market Competitive Landscape And Company Profiles

• 28.1. Cosentyx Drug Market Competitive Landscape
• 28.2. Cosentyx Drug Market Company Profiles
  • 28.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Sandoz Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.3. D. Vijay Pharma Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.4. KinBio Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.5. Zymeth Pharmaceuticals Private Limited Overview, Products and Services, Strategy and Financial Analysis

29. Global Cosentyx Drug Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Cosentyx Drug Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Cosentyx Drug Market

32. Recent Developments In The Cosentyx Drug Market

33. Cosentyx Drug Market High Potential Countries, Segments and Strategies

• 33.1 Cosentyx Drug Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Cosentyx Drug Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Cosentyx Drug Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer